Connection

TODD ROSENGART to Cell Transdifferentiation

This is a "connection" page, showing publications TODD ROSENGART has written about Cell Transdifferentiation.
Connection Strength

2.665
  1. Fibroblast transition to an endothelial "trans" state improves cell reprogramming efficiency. Sci Rep. 2021 11 19; 11(1):22605.
    View in: PubMed
    Score: 0.679
  2. Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming. J Am Heart Assoc. 2020 06 16; 9(12):e015686.
    View in: PubMed
    Score: 0.614
  3. MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1. J Am Heart Assoc. 2016 11 10; 5(11).
    View in: PubMed
    Score: 0.479
  4. Less may be more: Using small molecules to reprogram human cells into functional cardiomyocytes. J Thorac Cardiovasc Surg. 2017 01; 153(1):128-130.
    View in: PubMed
    Score: 0.473
  5. Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming. J Am Heart Assoc. 2021 12 21; 10(24):e022659.
    View in: PubMed
    Score: 0.170
  6. Reciprocity of Action of Increasing Oct4 and Repressing p53 in Transdifferentiation of Mouse Embryonic Fibroblasts into Cardiac Myocytes. Cell Reprogram. 2018 02; 20(1):27-37.
    View in: PubMed
    Score: 0.130
  7. In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration. J Thorac Cardiovasc Surg. 2017 02; 153(2):329-339.e3.
    View in: PubMed
    Score: 0.119
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.